AJP - Lung AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 290: L21-L31, 2006. First published August 12, 2005; doi:10.1152/ajplung.00155.2005
1040-0605/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/L21    most recent
00155.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welty-Wolf, K. E.
Right arrow Articles by Piantadosi, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welty-Wolf, K. E.
Right arrow Articles by Piantadosi, C. A.

Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure

Karen E. Welty-Wolf,1 Martha S. Carraway,1 Thomas L. Ortel,2 Andrew J. Ghio,1 Steven Idell,3 Jack Egan,4 Xiaoyun Zhu,4 Jin-an Jiao,4 Hing C. Wong,4 and Claude A. Piantadosi1

Divisions of 1Pulmonary and Critical Care Medicine and 2Hematology, Department of Medicine, Duke University Medical Center, Durham, North Carolina; 3Department of Specialty Care Services, University of Texas, Tyler, Texas; and 4Sunol Molecular, Miramar, Florida

Submitted 7 April 2005 ; accepted in final form 4 August 2005

Tissue factor expression in sepsis activates coagulation in the lung, which potentiates inflammation and leads to fibrin deposition. We hypothesized that blockade of factor X binding to the tissue factor-factor VIIa complex would prevent sepsis-induced damage to the lungs and other organs. Acute lung injury was produced in 15 adult baboons primed with killed Escherichia coli [1 x 109 colony-forming units (CFU)/kg], and then 12 h later, they were given 1 x 1010 CFU/kg live E. coli by infusion. Two hours after live E. coli, animals received antibiotics with or without monoclonal antibody to tissue factor intravenously to block tissue factor-factor X binding. The animals were monitored physiologically for 34 h before being killed and their tissue harvested. The antibody treatment attenuated abnormalities in gas exchange and lung compliance, preserved renal function, and prevented tissue neutrophil influx and bowel edema relative to antibiotics alone (all P < 0.05). It also attenuated fibrinogen depletion (P < 0.01) and decreased proinflammatory cytokines, e.g., IL-6 and -8 (P < 0.01), in systemic and alveolar compartments. Similar protective effects of the antibody on IL-6 and -8 expression and permeability were found in lipopolysaccharide-stimulated endothelial cells. Blockade of factor X binding to the tissue factor-factor VIIa complex attenuates lung and organ injuries in established E. coli sepsis by attenuating the neutrophilic response and inflammatory pathways.

thromboplastin; adult respiratory distress syndrome; multiple organ failure; septicemia; Papio



Address for reprint requests and other correspondence: K. E. Welty-Wolf, Dept. of Medicine, Box 3518, Duke Univ. Medical Center, Durham, North Carolina 27710 (e-mail: welty001{at}mc.duke.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. Matute-Bello, C. W. Frevert, and T. R. Martin
Animal models of acute lung injury
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L379 - L399.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. A. Bastarache, L. Wang, Z. Wang, K. H. Albertine, M. A. Matthay, and L. B. Ware
Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L874 - L881.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J. A Bastarache, L. Wang, T. Geiser, Z. Wang, K. H Albertine, M. A Matthay, and L. B Ware
The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor
Thorax, July 1, 2007; 62(7): 608 - 616.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Ahamed, F. Niessen, T. Kurokawa, Y. K. Lee, G. Bhattacharjee, J. H. Morrissey, and W. Ruf
Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia
Blood, June 15, 2007; 109(12): 5251 - 5259.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. B. Ware, E. Camerer, K. Welty-Wolf, M. J. Schultz, and M. A. Matthay
Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L307 - L311.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.